Isobionics, a part of the BASF’s Aroma Ingredients business, has opened a new distillation plant at Brightlands Chemelot Campus in Geleen, the Netherlands. The virtual opening is joined by Toine Janssen, CEO of Isobionics; Steffen Götz, head of BASF’s Aroma Ingredient business; Jurgen Hoekstra, managing director of BASF Netherlands; and Bert Kip, CEO of Brightlands Chemelot Campus.
Isobionics’s technology is based on fermentation, a traditional technique from processes such as brewing beer and baking bread. In this method, a substance is converted into a target product with the help of microorganisms such as bacteria or fungi. This process is based on renewable raw materials. Distillation is the last production step, yielding natural ingredients.
Janssen said: “With our distillation plant, we can expand our business even faster and serve the needs of our customers. We have many new ingredients in development, some of them will be already launched this year.”
Isobionics has launched Isobionics Santalol, which is produced on a biotechnological basis from renewable raw materials. The starting material for the fermentation process is corn starch obtained from corn grown in Europe. Isobionics Santalol is designed as an alternative to the original sandalwood oil, bringing warmth and volume to fragrance creation while conserving natural resources.